Annual report
4626.TEDINET S100QYYO
Period2022-04-01 → 2023-03-31
Filed2023-06-19
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥97.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥98.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥81.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥70.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥59.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥16.0bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥18.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥15.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥18.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥13.8bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.9bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.5bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥17.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.4bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥11.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥12.0bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥187.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥189.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥179.0bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥142.2bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥105.7bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥94.5bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥103.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥92.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥85.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥76.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥69.5bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥70.5bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥47.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥51.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥47.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥51.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥54.3bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥30.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥22.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥18.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥13.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥13.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥45.9bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.5bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥13.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥19.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥31.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥12.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥203.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.13 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.49 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.01 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥76.42 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,663.25 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,522.11 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,348.42 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,217.11 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,238.62 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 49.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.4% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 12.8% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 2,120 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 2,137 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 2,067 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,988 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,614 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥14.0bn | 2022-04-01 → 2023-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥11.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Revenue | ¥7.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.8bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥5.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥6.6bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.6bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥5.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥6.4bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥5.5bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥4.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.9bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥116.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥128.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥134.9bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥110.5bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥73.1bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥62.6bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥76.0bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥54.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥52.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥52.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥53.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥52.1bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥12.4bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥21.1bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥113.64 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥96.89 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.34 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.87 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥117.7 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥89 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥69.55 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥80.1 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65.1 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65.1 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥967.91 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥938.85 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥936.04 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥941.48 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥919.76 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 46.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.2% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.3% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.9% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.0% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 58,185,501 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 58,083,128 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,997,004 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,939,294 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 57,777,972 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 143 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 154 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 133 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 112 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 107 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 69
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥520m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥388m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 434 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥3.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥293m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥8.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | ¥26m |
| Electronics Materialsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥3.3bn |
| Electronics Materialsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥2.4bn |
| Electronics Materialsreportable segment | employees | at 2023-03-31 | 1281 pure |
| Electronics Materialsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥68.4bn |
| Electronics Materialsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥68.4bn |
| Electronics Materialsreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| Electronics Materialsreportable segment | segment assets | at 2023-03-31 | ¥72.1bn |
| Electronics Materialsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥15.8bn |
| Medical And Pharmaceuticalreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8.1bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥4.0bn |
| Medical And Pharmaceuticalreportable segment | employees | at 2023-03-31 | 405 pure |
| Medical And Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥25.4bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥25.4bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2023-03-31 | ¥75.4bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥11.4bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥6.4bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥93.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥93.9bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥0 |
| —segment total | segment assets | at 2023-03-31 | ¥147.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥17.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥97.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥97.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥293m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥155.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥17.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥332m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥382m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥3.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥3.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥8.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | ¥22m |
| Electronics Materialsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Electronics Materialsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Electronics Materialsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥71.1bn |
| Electronics Materialsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥71.1bn |
| Electronics Materialsreportable segment | segment assets | at 2022-03-31 | ¥78.2bn |
| Electronics Materialsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥16.9bn |
| Medical And Pharmaceuticalreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6.3bn |
| Medical And Pharmaceuticalreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥4.2bn |
| Medical And Pharmaceuticalreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥23.5bn |
| Medical And Pharmaceuticalreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥23.5bn |
| Medical And Pharmaceuticalreportable segment | segment assets | at 2022-03-31 | ¥65.1bn |
| Medical And Pharmaceuticalreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.4bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥9.5bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥6.5bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥94.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥94.6bn |
| —segment total | segment assets | at 2022-03-31 | ¥143.4bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥19.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥9.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥6.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥98.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥98.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥154m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥151.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥19.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,518
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | Prior1YearDuration | － | JPY |
| Increase in cash and cash equivalents from newly consolidated subsidiary cce | CurrentYearDuration | 15000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 51152000000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 47088000000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 24 | |
| Notes receivable trade | Prior1YearInstant | 2327000000 | JPY |
| Notes receivable trade | CurrentYearInstant | 1888000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 25231000000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 20846000000 | JPY |
| Trade notes receivable transferred by endorsement | Prior1YearInstant | 604000000 | JPY |
| Trade notes receivable transferred by endorsement | CurrentYearInstant | 610000000 | JPY |
| Accumulated depreciation ppe by group | Prior1YearInstant | -40766000000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -42863000000 | JPY |
| Salaries sga | Prior1YearDuration | 3858000000 | JPY |
| Salaries sga | CurrentYearDuration | 4096000000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 569000000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 458000000 | JPY |
| Commission fee sga | Prior1YearDuration | 1943000000 | JPY |
| Commission fee sga | CurrentYearDuration | 2288000000 | JPY |
| Depreciation sga | Prior1YearDuration | 2694000000 | JPY |
| Depreciation sga | CurrentYearDuration | 2674000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 3436000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 4275000000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 207000000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 202000000 | JPY |
| Business consignment expenses sga | Prior1YearDuration | 1202000000 | JPY |
| Business consignment expenses sga | CurrentYearDuration | 1198000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 3611000000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 4483000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00913-000ElectronicsMaterialsReportableSegmentsMember | 71093000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 23467000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReportableSegmentsMember | 94560000000 | JPY |
| Revenues from external customers | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3405000000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 97966000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00913-000ElectronicsMaterialsReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 154000000 | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 154000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00913-000ElectronicsMaterialsReportableSegmentsMember | 71093000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 23467000000 | JPY |
| Net sales | Prior1YearDuration_ReportableSegmentsMember | 94560000000 | JPY |
| Net sales | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3560000000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 98121000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E00913-000ElectronicsMaterialsReportableSegmentsMember | 16927000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E00913-000MedicalAndPharmaceuticalReportableSegmentsMember | 2400000000 | JPY |
| Operating income | Prior1YearDuration_ReportableSegmentsMember | 19328000000 | JPY |
| Operating income | Prior1YearDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 22000000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 19350000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E00913-000ElectronicsMaterialsReportableSegmentsMember | 78238000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |